The current price of BDRX is $2.41 — it has decreased by 10.41% since the previous close. Data as of Nov 5, 2026.
BDRX is down 37.08% over the past week, down 50.92% over the past month and down 98.91% over the past year. The price is below its 200-day moving average of $24.08.
Biodexa Pharmaceuticals Plc has a market capitalization of $224.77K. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Biodexa Pharmaceuticals Plc posted earnings of $0 per share. Upcoming reports are listed in the earnings calendar.
Biodexa Pharmaceuticals Plc has not paid any dividends over the past year.
Companies most comparable to Biodexa Pharmaceuticals Plc include Estrella Immunopharma, Inc., Kazia Therapeutics Ltd ADR, BioVie Inc., InMed Pharmaceuticals Inc. and CNS Pharmaceuticals, Inc.
In the latest trading session BDRX moved between $2.41 and $2.57, a range of 6.64% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Biodexa Pharmaceuticals Plc shows a strong sell rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Biodexa Pharmaceuticals Plc is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks BDRX has traded between $2.41 and $357.60. The current price is 99.33% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.